Alembic Pharmaceuticals receives NCLT approval for scheme of arrangement

Image
Capital Market
Last Updated : Sep 01 2022 | 1:16 PM IST
Alembic announced that Hon'ble National Company Law Tribunal, Ahmedabad Bench ("NCLT"), vide its Order dated 29 August 2022, has sanctioned the Scheme of Arrangement in the nature of Amalgamation between Aleor Dermaceuticals and Alembic Pharmaceuticals and their respective shareholders (Scheme) pursuant to the provisions of Section 230 to 232 and other applicable provisions of the Companies Act, 2013 and rules made thereunder.

The Scheme will become effective upon filing of the said Order with the Registrar of Companies, Gujarat.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 01 2022 | 12:36 PM IST

Next Story